Synthonics, Inc, based in Blacksburg, VA, is a cutting-edge pharmaceutical company specializing in metal-coordinated drug delivery technologies. Led by a team of industry experts, including co-founder and President Dr. Thomas Piccariello, the company boasts a strong track record of innovation and success in the fields of synthetic chemistry, pharmacology, and chemical manufacturing.
With a focus on developing novel drug delivery solutions, Synthonics has garnered attention for its groundbreaking work in creating metal-coordinated pharmaceuticals. The company's leadership team, which includes CEO John Tinkham and Chief Medical Officer Dr. Scott Palmer, brings a wealth of experience in technology licensing, mergers and acquisitions, and medical research, positioning Synthonics as a key player in the pharmaceutical industry.
Generated from the website